Gilead Sciences (France)
Gilead Sciences, Inc. is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the treatment of HIV/AIDS, hepatitis B, hepatitis C, influenza, and COVID-19, including ledipasvir/sofosbuvir and sofosbuvir. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Gilead Sciences (France), France, covering academic research published from 2000 to 2024. Read More.
Open Access Percentage
49%
Total
Publications
236
Total Open
Publications
116
Total
Citations
7.3K
Open Access
Percentage
49%
Total
Publications
236
Total Open
Publications
116
Total
Citations
7.3K
Breakdown
Publisher Open
31%
Both
14%
Other Platform Open
4%
Closed
51%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 33%
34
Hybrid 21%
22
No Guarantees 46%
48
Other Platform Open
Domain 81%
34
Institution 24%
10
Other Internet 19%
8
Preprint 0%
0
Public 0%
0
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 34 |
DOI | Other Internet | 8 |
University of Michigan - Deep Blue | Institution | 2 |
University of Genoa - CINECA IRIS Institutial Research Information System | Institution | 2 |
Le Centre pour la Communication Scientifique Directe - HAL - Diderot | Institution | 2 |
Belarusian State Pedagogical University - Belarusian State Pedagogical University repository | Institution | 2 |
Washington University School of Medicine - Digital Commons@Becker | Institution | 1 |
Utrecht University - Utrecht University Repository | Institution | 1 |
University of Melbourne - Minerva Access | Institution | 1 |
Universite de Bordeaux - Oskar-Bordeaux | Institution | 1 |